Uberoi Guneesh S, Uberoi Angad S, Bhutani Manoop S
Department of Gastroenterology, Hepatology and Nutrition-Unit 1466, UT MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030-4009, USA.
Curr Gastroenterol Rep. 2017 Oct 6;19(11):57. doi: 10.1007/s11894-017-0594-5.
Locally advanced esophageal cancer is frequently treated preoperatively with chemotherapy and radiation. The degree of response to this preoperative therapy varies in different patients, and a complete pathological response (pCR) has important implications in the management and prognosis of these patients. This is a review of the different modalities currently available to detect pCR and the clinical context of their use.
While research is still ongoing, no single technique has emerged as the modality of choice to reliably predict pCR in all patients. Studies investigating the sensitivity, specificity, and accuracy of these modalities have had promising results, but no single modality has been firmly validated as the modality if choice. The emergence of functional imaging techniques and the use of biomarkers are newer developments which need further evaluation before adoption in routine clinical practice. While no single technique reliably predicts pCR, a combination of imaging and diagnostic modalities (endoscopic appearance, biopsy, EUS, and PET/CT) may provide a better diagnostic yield rather than any of these modalities taken alone.
局部进展期食管癌常术前接受化疗和放疗。不同患者对这种术前治疗的反应程度各异,而完全病理缓解(pCR)对这些患者的管理和预后具有重要意义。本文综述了目前可用于检测pCR的不同方法及其临床应用背景。
尽管研究仍在进行中,但尚无单一技术成为在所有患者中可靠预测pCR的首选方法。对这些方法的敏感性、特异性和准确性进行研究取得了有前景的结果,但尚无单一方法被确认为首选方法。功能成像技术的出现和生物标志物的应用是较新的进展,在常规临床实践中采用之前需要进一步评估。虽然没有单一技术能可靠预测pCR,但成像和诊断方法(内镜表现、活检、超声内镜和PET/CT)的联合应用可能比单独使用这些方法中的任何一种提供更好的诊断效果。